Designed specifically for new and emerging companies such as Kaleido Biosciences, The Quick to Care™ program is an integrated solution that combines drug substance and drug product development, clinical manufacturing, forecasting, demand planning and clinical trial supply execution managed by a single program manager.
With many end users now demanding streamlined operations, high-density culture in fed-batch modes, even higher production by perfusion cultures, and contrastingly gentle operations required in microcarrier applications, standard S.U.B. offerings must keep pace with the ever-evolving needs of the bioprocessing industry. Read about recent enhancements that are helping keep up with these increasing demands.
Dry blending is an indispensable operation in the manufacture of multivitamins, sports supplements, herbal extracts, meal-replacements, green food powders and other nutraceutical products.
This application note describes the production of adenovirus in HEK293 cells cultured in HyClone™ CDM4HEK293 culture medium.
This article disucsses two trends turning the flowmeter industry on its ear: advances in flowmeter diagnostics and the adoption of smartphone-like technology to improve access and communications.
Recent developments eliminate the need for unnecessary calibrations and speed up the time it takes to do calibrations in the field.
Here, we describe the development of two effective downstream processes for purification of adenovirus from cell culture harvest.
Strict regulations regarding the manufacture of HPAPIs require that pharmaceutical companies and CMOs carefully select equipment, outline processes and deploy appropriate containment strategies.
Since procuring equipment for your facility is a critical step for any manufacturing organization, it is in a manufacturer’s best interest to turn to an organization that can serve as a strategic procurement partner.
With patients’ lives at the end of the pipeline, biologics contract manufacturing needs to be safe, reliable and consistent in supply. The developers of these large molecule drugs, however, are also operating in a highly competitive space. Speed-to-market is imperative, along with efficient processes and low costs. A lot of this will rest on the quality of the cell line development and the expertise of the biologics CMO you choose.
Cannabis-infused products and medical marijuana are at the forefront of an innovative and promising industry. Fueled by a growing consumer base and increasing investor enthusiasm, the cannabis industry is opening the doors to a new generation of cosmetics, beverages, foods, nutritional supplements, pharmaceuticals, and even pet food & wellness products.
Bringing together all hardware, software, wetware and documentation into a ready to produce package.
Leverage our experience to give your product an inside edge. Our vast knowledge is based on commercial success that we then apply to find the right solution tailored to meet your product's needs.
MaxiCaps® MR is a fully contained single-use assembly with up to 27 m2 filtration area, designed for large scale filtration in biopharmaceutical applications.